Mirogab Tablet

Mirogabalin
2.5 mg
Beacon Pharmaceuticals Ltd.
Pack size 30's pack
Dispensing mode
Source
Agent
Retail Price 12.00 AED

Indications

Mirogab Tablet is used for: Peripheral neuropathic pain, Diabetic peripheral neuropathic pain, Postherpetic Neuralgia

Adult Dose

Oral Tablet In general, for adults, the initial dose of 5 mg of Mirogabalin is orally administered twice daily, then the dose can be gradually increased by 5 mg at intervals of 1 week or longer. The dose may be adjusted according to the patient's age and symptoms in the range of 10 mg to 15 mg, and administered twice daily.

Child Dose

Renal Dose

Administration

Contra Indications

Mirogabalin is contraindicated in patients with known hypersensitivity to Mirogabalin or any of its components. Patients with severe Hepatic & Renal impairment.

Precautions

Dose adjustment is needed in patients with renal dysfunction. Mirogabalin may cause dizziness or somnolence, the patient should avoid operating in potentially hazardous activities such as driving a car. Elderly patients should be aware of falling and fractures. Mirogabalin may cause blurred vision or double vision. Mirogabalin may cause weight gain.

Pregnancy-Lactation

Pregnant women: For pregnant or potentially pregnant women, administer only if the therapeutic benefit outweighs the risks. The presence in placental passage has been reported in animal studies. Lactating women: Consider the therapeutic and breastfeeding benefits then consider continuing or discontinuing breastfeeding. It has been reported in animal studies that it is transferred into milk.

Interactions

Mirogabalin does not inhibit or induce major human CYP molecular species and does not inhibit activities of drug transporters. Co-administrated with OAT1, OAT3, OCT2, MATE1, MATE2-K or UGT inhibitor may increase mirogabalin exposure, so used with caution. Co-administration of Mirogabalin with Cimetidine or Probenecid may raise the Mirogabalin plasma concentration. Importantly, if Mirogabalin is taken with Lorazepam, the depressive effects on the CNS may be potentiated.

Adverse Effects

Side effects of Mirogabalin : Somnolence, dizziness, edema, weight gain and headache.

Mechanism of Action

Mirogabalin has selective and potent binding affinities for α2δ-1 subunit of VGCCs (Voltage Gated Calcium Channel), which reduces calcium (Ca2+) influx and neurotransmission in DRG (Dorsal root ganglia), inhibiting neurotransmitter release in presynaptic neuron endings, thus gives analgesic effect.

Note

Mirogab 2.5 mg Tablet manufactured by Beacon Pharmaceuticals Ltd.. Its generic name is Mirogabalin. Mirogab is availble in Bangladesh. Farmaco BD drug index information on Mirogab Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Mirogabalin :